La Merie Publishing

Set up in 2002, La Merie Publishing is an authoritative supplier of the cutting-edge information on the biopharmaceutical industry, with a special focus on the research and development pipeline and covering issues related to biologics, including peptides, antibodies, DNA, RNA, proteins and cell therapy.

The company’s service portfolio is represented by various formats and price levels, and includes Brief Reports, Full Reports and Competitor Analysis Reports. Competitor Analysis Reports present no frills, but accurate data on the pipeline of research and development projects for diseases, targets, companies and technologies. The data are fully referenced and delivered in a tabular format. Brief Reports covering Target Pipelines contain all-round assessments of both business and scientific perspectives of new targets. Full Reports present deep analyses of product portfolios, competitive landscape, R&D pipelines and discussions of the pipeline perspectives.

Research Reports By La Merie Publishing

Found 130 publications
Competitor Analysis: Cancer Vaccines US$ 1,112.00 Mar, 2014 179 pages
Competitor Analysis: Immunocytokines US$ 334.00 Jan, 2014 48 pages
Competitor Analysis: Pim Kinase Inhibitors US$ 132.00 Sep, 2013 17 pages
Competitor Analysis: Wnt Pathway Inhibitors US$ 132.00 Sep, 2013 16 pages
Competitor Analysis: c-MET/HGF Inhibitors US$ 394.00 Jul, 2013 57 pages
Competitor Analysis: Coagulation Factors US$ 800.00 May, 2013 158 pages
Competitor Analysis: Interferon US$ 590.00 Apr, 2013 89 pages
Competitor Analysis: Human Growth Hormone (hGH) US$ 395.00 Apr, 2013 49 pages
Competitor Analysis: Insulin US$ 590.00 Apr, 2013 89 pages
1 2 3
Skip to top

News & Press-Releases by La Merie Publishing